Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
How do you help patients understand the difference between prolonged morning stiffness and pain?
Related Questions
What is your approach for an RA patient with lung cancer who is starting immunotherapy?
Are there concerns with combining anti-IL5 biologics (mepolizumab or benralizumab) for severe asthma with other biologics for RA (e.g. TNFi)?
How do you approach patients with RA and severe bronchiectasis with associated findings of UIP?
When considering a biologic for seropositive RA after failure of methotrexate or triple therapy, do you consider using abatacept as a first line biologic or would prefer choosing TNFi?
How do you approach treatment of early onset RA with minimal peripheral disease and aggressive cervical atlantoaxial involvement?
What is your approach to monitoring patients referred for high titer +RF and +CCP but without active symptoms of inflammatory arthritis?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
Would you escalate therapy in a patient with rheumatoid arthritis without synovitis, but a new rheumatoid nodule?
When considering biologic therapy after failure of MTX or triple therapy, do you consider using Abatacept as a first line biologic?
What is your approach to biologic therapy in older adults (80+) and CKD with RA?
